ATE345354T1 - Methode zur identifizierung von helicobacter antigenen - Google Patents

Methode zur identifizierung von helicobacter antigenen

Info

Publication number
ATE345354T1
ATE345354T1 AT01931657T AT01931657T ATE345354T1 AT E345354 T1 ATE345354 T1 AT E345354T1 AT 01931657 T AT01931657 T AT 01931657T AT 01931657 T AT01931657 T AT 01931657T AT E345354 T1 ATE345354 T1 AT E345354T1
Authority
AT
Austria
Prior art keywords
helicobacter
helicobacter antigens
antigens
identifying helicobacter
identifying
Prior art date
Application number
AT01931657T
Other languages
English (en)
Inventor
Thomas F Meyer
Peter Jungblut
Dirk Bumann
Anton Aebischer
Gaby Haas
Ursula Zimny-Arndt
Stephanie Lamer
Galip Karaali
Nicolas Sabarth
Meike Wendland
Original Assignee
Max Planck Gesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Planck Gesellschaft filed Critical Max Planck Gesellschaft
Application granted granted Critical
Publication of ATE345354T1 publication Critical patent/ATE345354T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT01931657T 2000-04-27 2001-04-26 Methode zur identifizierung von helicobacter antigenen ATE345354T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00108968 2000-04-27
EP01101439 2001-01-23

Publications (1)

Publication Number Publication Date
ATE345354T1 true ATE345354T1 (de) 2006-12-15

Family

ID=26070866

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01931657T ATE345354T1 (de) 2000-04-27 2001-04-26 Methode zur identifizierung von helicobacter antigenen

Country Status (6)

Country Link
US (1) US20030180330A1 (de)
EP (1) EP1278768B1 (de)
AT (1) ATE345354T1 (de)
AU (1) AU2001258373A1 (de)
DE (1) DE60124526D1 (de)
WO (1) WO2001083531A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6290962B1 (en) * 1992-11-03 2001-09-18 Oravax, Inc. Urease-based vaccine and treatment for helicobacter infection
ATE353337T1 (de) * 1996-06-10 2007-02-15 Thomas Boren Adhesin aus heliobacter pylori, welches an blutgruppenantigene bindet
US6790950B2 (en) * 1999-04-09 2004-09-14 Pharmacia & Upjohn Company Anti-bacterial vaccine compositions
DE60138981D1 (de) * 2000-05-18 2009-07-30 Meridian Bioscience Inc Immunoassay für H. pylori in Fäkalienproben mit Hilfe von gattungsspezifischen Antikörpern
CA2414846A1 (en) * 2000-07-05 2002-01-24 Merieux Oravax Immunological combinations for prophylaxis and therapy of helicobacter pylori infection
CA2351110A1 (en) * 2000-07-17 2002-01-17 Akzo Nobel N.V. Helicobacter felis vaccine
US20030013138A1 (en) * 2001-05-29 2003-01-16 The Regents Of The University Of Michigan Systems and methods for the analysis of proteins
US20050048077A1 (en) * 2002-02-21 2005-03-03 George Sachs Compositions, test kits and methods for detecting helicobacter pylori
EP1837345A1 (de) * 2006-03-23 2007-09-26 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Pharmazeutische Zusammensetzungen, die Cholesteryl-alpha-glukosyltransferase zur Behandlung von Helicobacter pylori Infektionen enthalten
RU2017100658A (ru) 2014-06-30 2018-07-30 Мёрдок Чилдренс Рисерч Инститьют ТЕРАПЕВТИЧЕСКОЕ СРЕДСТВО ПРОТИВ Helicobacter
BR112018012033A2 (pt) 2015-12-14 2018-12-04 Max Planck Gesellschaft composição imunogênica e método para detectar infecção por h. pylori em um sujeito
EP3272354A1 (de) 2016-07-20 2018-01-24 Technische Universität München Wirkstoffe und verfahren zur vorbeugung oder behandlung von h.-pylori-infektionen
CN111793137A (zh) * 2019-12-12 2020-10-20 南京蛋球球生物医学技术合伙企业(有限合伙) 一种Hp四价抗原及其制备方法与应用
JP6867529B1 (ja) * 2020-03-16 2021-04-28 栄研化学株式会社 ヘリコバクター・ピロリ検出用抗体
CN114907491B (zh) * 2022-06-21 2023-06-16 中国科学院西北生态环境资源研究院 一种多表位肽、幽门螺旋杆菌八价多表位疫苗及制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US52799A (en) * 1866-02-20 Improved apparatus for driving metal or wood into the ground
US158396A (en) * 1875-01-05 Improvement in street-lamps
US115078A (en) * 1871-05-23 Improvement in whiffletrees
US160456A (en) * 1875-03-02 Improvement in locomotive spark-arresters
ATE229978T1 (de) * 1994-07-01 2003-01-15 Chiron Corp Helicobacter proteine und impstoffe
US6762295B2 (en) * 1995-04-21 2004-07-13 Csl Limited Protective helicobacter antigens
AR003125A1 (es) * 1995-06-01 1998-07-08 Astra Ab Antigenos bacterianos para el diagnostico de infecciones con helicobacter pylori, una molecula de adn que lo codifica, un vector, una celula huesped,procedimiento para producir el polipeptido, composiciones para vacunas adecuadas para uso terapeutico y profilactico, el uso del polipeptido en la
EP0835928A1 (de) * 1996-10-11 1998-04-15 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Berlin Helicobacter Pylori Lebendimpfstoff
US20040052799A1 (en) * 1996-11-15 2004-03-18 Astra Aktiebolag Nucleic acid and amino acid sequences relating to Helicobacter pylori for diagnostics and therapeutics
NZ338039A (en) * 1997-04-01 2001-04-27 Human Genome Sciences Inc Identification of polynucleotides encoding helicobacter polypeptides in the helicobacter genome
EP0977864A2 (de) * 1997-04-25 2000-02-09 Genelabs Technologies, Inc. Antigenische zusammensetzungen und verfahren zur nachweis von helicobacter pylori
US5942409A (en) * 1998-07-31 1999-08-24 Byk Gulden Lomberg Chemische Fabrik Gmbh Process for identification of substances modulating ureI dependent mechanisms of Helicobacter pylori metabolism

Also Published As

Publication number Publication date
AU2001258373A1 (en) 2001-11-12
WO2001083531A1 (en) 2001-11-08
DE60124526D1 (de) 2006-12-28
EP1278768B1 (de) 2006-11-15
EP1278768A1 (de) 2003-01-29
US20030180330A1 (en) 2003-09-25

Similar Documents

Publication Publication Date Title
ATE345354T1 (de) Methode zur identifizierung von helicobacter antigenen
DK1434791T3 (da) Specifikke bindingsmidler til human angiopoietin-2
DK1212422T3 (da) Humane CTLA-4-antistoffer og anvendelserne deraf
ZA200501054B (en) Transplant acceptance inducing cells of monocytic origin and their preparation and use.
EA200600591A1 (ru) МОДУЛИРОВАНИЕ ЭКСПРЕССИИ eIF4E
UA93855C2 (ru) Вакцина, способствует росту, базирующейся ha нейтрализующем эпитопе
HUP0303738A2 (hu) Új peszticid toxinok
ATE378403T1 (de) Transchromosomale transgen-nagetiere zur herstellung von humänen antikörpern
ATE348633T1 (de) Verfahren zur verstärkung einer immunantwort von nukleinsäureimpfungen
DK1668001T3 (da) Substituerede heteroarylbenzofuransyrer
ATE318134T1 (de) Methode zur herstellung lycopen-konzentrats frei von organischen lösungsmitteln, das resultierende konzentrat und dieses konzentrat enthaltende zusammensetzungen
ATE355375T1 (de) Bakterioferritin aus helicobacter pylori
EE200500012A (et) Peptiid-pähine passiivne immunoteraapia ateroskleroosi raviks
DE60139544D1 (de) Veränderte, fluoreszierende proteine
DE60234250D1 (de) Vorrichtung zur Zell- bzw. Gewebezüchtung
DE69923559D1 (de) Methoden zur inhibierung von helicobacter pylori
DE60107718D1 (de) Konservierung von zellen
BR9808226A (pt) Coronavìrus respiratório bovino como uma vacina
NO20051301L (no) Proteintyrosinforfataseinhibitorer
BR0008187A (pt) Controle biológico de nematódeos
ATE476987T1 (de) Zusammensetzungen und methoden zur behandlung von candidosen
WO2001096873A3 (en) Method for identifying apoptosis-modified proteins
ATE359815T1 (de) Streptococcus-phocae-vakzine
ATE343387T1 (de) S-methyl-dihydro-ziprasidon zur behandlung von augenerkrankungen.
DE69838615D1 (de) ppGpp-SYNTHETASE UND EXPRESSIONSSYSTEME ZUR VERBESSERTEN HERSTELLUNG VON PROTEINEN

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties